{"schema_version":"alpha-company-profile-public-v2","slug":"amylyx-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc","published_on":"2026-09-16T04:45:45.384278+00:00","last_reviewed_on":"2026-09-16T04:45:45.384278+00:00","identity":{"legal_name":"Amylyx Pharmaceuticals, Inc.","display_name":"Amylyx Pharmaceuticals, Inc.","headline":"Canonical company identity and public leadership record.","description":"Alpha's canonical identity and public leadership record for Amylyx Pharmaceuticals, Inc..","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001658551","logo":"https://cdn.brandfetch.io/ticker/amlx/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/amlx/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"Amylyx Pharmaceuticals, Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-16T04:45:45.384278+00:00"},"security_listings":[{"ticker":"AMLX","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"Amylyx Pharmaceuticals, Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/amylyx-pharmaceuticals-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-16T04:45:45.384278+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":10,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":10,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":0,"sources":2,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-16T04:45:45.384278+00:00","observed_at":"2026-09-16T04:45:45.384278+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"amylyx-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc"},"publication":{"published_at":"2026-09-16T04:45:45.384278+00:00","last_reviewed_at":"2026-09-16T04:45:45.384278+00:00","as_of":"2026-09-16T04:45:45.384278+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/amylyx-pharmaceuticals-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"amylyx-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc","as_of":"2026-09-16T04:45:45.384278+00:00","last_reviewed_at":"2026-09-16T04:45:45.384278+00:00","identity":{"legal_name":"Amylyx Pharmaceuticals, Inc.","display_name":"Amylyx Pharmaceuticals, Inc.","description":null,"jurisdiction":null,"country":"US","sector":null,"industry":null,"website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001658551","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"AMLX","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"796917e6-af11-4a34-8e44-cedd29ebd591","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-16","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"bernhardt-zeiher-m-d","display_name":"Bernhardt Zeiher, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"},"headshot_url":null},{"person_slug":"daphne-quimi","display_name":"Daphne Quimi","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"},"headshot_url":null},{"person_slug":"george-mclean-milne-jr-ph-d","display_name":"George Mclean Milne Jr., Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"},"headshot_url":null},{"person_slug":"joshua-cohen","display_name":"Joshua Cohen","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2014-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"},"headshot_url":null},{"person_slug":"justin-klee","display_name":"Justin Klee","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2014-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"},"headshot_url":null},{"person_slug":"karen-firestone","display_name":"Karen Firestone","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"},"headshot_url":null},{"person_slug":"paul-fonteyne","display_name":"Paul Fonteyne","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","source_url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-23","last_checked_at":"2026-04-24T15:47:01.041+00:00"},"headshot_url":null}],"executives":[],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"NOT_ASSERTED","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc#profile","url":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc","dateModified":"2026-09-16T04:45:45.384278+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc#organization","legalName":"Amylyx Pharmaceuticals, Inc.","name":"Amylyx Pharmaceuticals, Inc.","url":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","member":{"@type":"Person","name":"Bernhardt Zeiher, M.D.","url":"https://registry.alpha.ac/people/bernhardt-zeiher-m-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Daphne Quimi","url":"https://registry.alpha.ac/people/daphne-quimi"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2015-01-01","member":{"@type":"Person","name":"George Mclean Milne Jr., Ph.D.","url":"https://registry.alpha.ac/people/george-mclean-milne-jr-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2014-01-01","member":{"@type":"Person","name":"Joshua Cohen","url":"https://registry.alpha.ac/people/joshua-cohen"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2014-01-01","member":{"@type":"Person","name":"Justin Klee","url":"https://registry.alpha.ac/people/justin-klee"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","member":{"@type":"Person","name":"Karen Firestone","url":"https://registry.alpha.ac/people/karen-firestone"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Paul Fonteyne","url":"https://registry.alpha.ac/people/paul-fonteyne"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/amylyx-pharmaceuticals-inc"},"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"}},"canonical_source":"aegis_canonical"}